171 related articles for article (PubMed ID: 28735371)
1. Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).
Wiener L; Battles H; Bedoya SZ; Baldwin A; Widemann BC; Pao M
J Genet Couns; 2018 Feb; 27(1):115-123. PubMed ID: 28735371
[TBL] [Abstract][Full Text] [Related]
2. Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinics.
Wiener L; Battles H; Zadeh S; Widemann BC; Pao M
Psychooncology; 2017 Apr; 26(4):461-468. PubMed ID: 26620722
[TBL] [Abstract][Full Text] [Related]
3. Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.
Wolters PL; Burns KM; Martin S; Baldwin A; Dombi E; Toledo-Tamula MA; Dudley WN; Gillespie A; Widemann BC
Am J Med Genet A; 2015 Sep; 167A(9):2103-13. PubMed ID: 25976979
[TBL] [Abstract][Full Text] [Related]
4. Caregiver distress and patient health-related quality of life: psychosocial screening during pediatric cancer treatment.
Pierce L; Hocking MC; Schwartz LA; Alderfer MA; Kazak AE; Barakat LP
Psychooncology; 2017 Oct; 26(10):1555-1561. PubMed ID: 27321897
[TBL] [Abstract][Full Text] [Related]
5. The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives.
Draucker CB; Nutakki K; Varni JW; Swigonski NL
J Spec Pediatr Nurs; 2017 Apr; 22(2):. PubMed ID: 28198162
[TBL] [Abstract][Full Text] [Related]
6. [Psychological distress in adults with neurofibromatosis type 1: a longitudinal study].
Reichardt C; Scherwath A; Felix Mautner V; Bullinger M; Petersen-Ewert C
Psychother Psychosom Med Psychol; 2013 Feb; 63(2):85-92. PubMed ID: 23408303
[TBL] [Abstract][Full Text] [Related]
7. What factors influence parents' perception of the quality of life of children and adolescents with neurocardiogenic syncope?
Grimaldi Capitello T; Fiorilli C; Placidi S; Vallone R; Drago F; Gentile S
Health Qual Life Outcomes; 2016 May; 14():79. PubMed ID: 27188269
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1.
Graf A; Landolt MA; Mori AC; Boltshauser E
J Pediatr; 2006 Sep; 149(3):348-53. PubMed ID: 16939745
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1.
Cipolletta S; Spina G; Spoto A
Child Care Health Dev; 2018 Mar; 44(2):260-268. PubMed ID: 28776749
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior.
Krab LC; Oostenbrink R; de Goede-Bolder A; Aarsen FK; Elgersma Y; Moll HA
J Pediatr; 2009 Mar; 154(3):420-5, 425.e1. PubMed ID: 18950800
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.
Domon-Archambault V; Gagnon L; Benoît A; Perreault S
J Child Neurol; 2018 Mar; 33(3):225-232. PubMed ID: 29318935
[TBL] [Abstract][Full Text] [Related]
12. Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1.
Varni JW; Nutakki K; Swigonski NL
Am J Med Genet A; 2019 Aug; 179(8):1476-1482. PubMed ID: 31081992
[TBL] [Abstract][Full Text] [Related]
13. The self-concept of children and adolescents with neurofibromatosis type 1.
Barton B; North K
Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
[TBL] [Abstract][Full Text] [Related]
15. Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1.
Varni JW; Nutakki K; Swigonski NL
Eur J Paediatr Neurol; 2020 Sep; 28():64-69. PubMed ID: 32847704
[TBL] [Abstract][Full Text] [Related]
16. Distress screening, rater agreement, and services in pediatric oncology.
Patel SK; Mullins W; Turk A; Dekel N; Kinjo C; Sato JK
Psychooncology; 2011 Dec; 20(12):1324-33. PubMed ID: 20925136
[TBL] [Abstract][Full Text] [Related]
17. Use of the Distress Thermometer in a cancer helpline context: Can it detect changes in distress, is it acceptable to nurses and callers, and do high scores lead to internal referrals?
Linehan K; Fennell KM; Hughes DL; Wilson CJ
Eur J Oncol Nurs; 2017 Feb; 26():49-55. PubMed ID: 28069152
[TBL] [Abstract][Full Text] [Related]
18. Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image.
Granström S; Langenbruch A; Augustin M; Mautner VF
Dermatology; 2012; 224(2):160-7. PubMed ID: 22508340
[TBL] [Abstract][Full Text] [Related]
19. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions.
Johnson NS; Saal HM; Lovell AM; Schorry EK
J Pediatr; 1999 Jun; 134(6):767-72. PubMed ID: 10356149
[TBL] [Abstract][Full Text] [Related]
20. [Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].
Saltık S; Başgül ŞS
Turk Psikiyatri Derg; 2013; 24(1):25-34. PubMed ID: 23446537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
